# OnCo record hla-dra (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/hla-dra/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "hla-dra" ;
  schema:name "HLA-DRA"@en ;
  schema:alternateName "major histocompatibility complex, class II, DR alpha"@en, "HLA class II histocompatibility antigen, DR alpha chain"@en, "HLA-DRA1"@en, "HLA-DRA" ;
  schema:description "HLA-DRA (HLA class II histocompatibility antigen, DR alpha chain) is a gene. The public catalogues list it as a drug target and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Melanoma."@en ;
  schema:url <https://onco.cc/targets/hla-dra/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4947>, <https://www.uniprot.org/uniprotkb/P01903/entry>, <https://www.ncbi.nlm.nih.gov/gene/3122>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000204287> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "other" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:4947>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000204287>, <https://www.uniprot.org/uniprotkb/P01903/entry>, <https://www.ncbi.nlm.nih.gov/gene/3122> ;
  onco:related <https://onco.cc/collections/civic/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> .